EUVIMEDEUVIMED entdecken
Crossref

A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype

Jiaxuan Yang iD, Lina Ni, Aijing Li, Minghao Li, Shulin Ruan, Dong Xiang, Ziyan Zhu, Luyi Ye iD

Transfusion Medicine · 2024-02 · 34 (1) · 39-45

DOI: 10.1111/tme.13016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine, online erschienen am 10.11.2023. Verfasst von Jiaxuan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunohematology Lab, Shanghai Institute of Blood Transfusion, Shanghai Blood Center, Shanghai, China. Hauptthemen laut MEDLINE: RNA Splicing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to investigate the molecular mechanism of the Jk(a‐b‐) phenotype in a Chinese transfusion patient.

Background

Many different mutation types relating to Jk(a‐b‐) phenotype have been reported. However, the splice‐site mutation is relatively rare and the related functional verification is lacking. Materials and Methods In this study, the blood sample was collected from a transfusion patient with the Jk(a‐b‐) phenotype. Serotyping was performed using routine serological methods. The exons sequences and coding regions of the JK gene were amplified using polymerase chain reaction and directly sequenced. To perform a minigene splicing assay, the intronic mutation sequences were cloned into a pSPL3 splice reporting vector. The splicing reporter minigene assay was performed in HEK 293T cells.

Results

The Jk(a‐b‐) phenotype of the blood sample was identified through serological testing. Sequencing results revealed that the sample had a novel homozygous splice‐site mutation JK*02N (NM_015865.7: c.663+3A>C). Further analysis, including cDNA sequencing and minigene splicing assay, confirmed that the novel splice‐site mutation resulted in exon skipping. Interestingly, different numbers of exons being skipped were obtained by the two methods.

Conclusion

This study revealed a novel homozygous splicing‐site mutation associated with the Jk(a‐b‐) phenotype in Chinese population. Our results emphasise the importance of the in vitro functional method minigene splicing assay, while also acknowledging its potential limitations when compared to cDNA sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA SplicingHumansDNA, ComplementaryMutationExonsPhenotype

Stichwörter der Autor:innen

Jk(a-b-) phenotypecDNA sequencingminigene splicing assaysplicing-site mutation

Substanzen

DNA, Complementary

Autor:innen und Institutionen

  • Immunohematology Lab, Shanghai Institute of Blood Transfusion, Shanghai Blood Center, Shanghai, China.
  • Department of Blood Transfusion, Weihai Central Hospital, Weihai, China.

ORCID-Profile: Jiaxuan Yang, Luyi Ye

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Ni, L., Li, A., Li, M., Ruan, S., Xiang, D., Zhu, Z., & Ye, L. (2024). A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype. Transfusion Medicine, 34(1), 39-45. https://doi.org/10.1111/tme.13016

Vancouver

Yang J, Ni L, Li A, Li M, Ruan S, Xiang D, et al. A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype. Transfusion Medicine. 2024;34(1):39-45. doi:10.1111/tme.13016

BibTeX
@article{Yang2024,
  author = {Yang, Jiaxuan and Ni, Lina and Li, Aijing and Li, Minghao and Ruan, Shulin and Xiang, Dong and Zhu, Ziyan and Ye, Luyi},
  title = {A novel homozygous splice‐site mutation of JK gene leads to Jk(a‐b‐) phenotype},
  journal = {Transfusion Medicine},
  year = {2024},
  volume = {34},
  number = {1},
  pages = {39--45},
  doi = {10.1111/tme.13016}
}
Kostenlos starten →